S
SanRo Clinical Research Group | Bryant, AR
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Azetukalner
LY3502970
Centanafadine
Orforglipron
SEP-4199
Metformin
SP-624
JZP150
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...
Enrolling
Major Depressive Disorder
Drug: Azetukalner
Drug: Placebo
This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depr...
Enrolling
Major Depressive Disorder
Drug: SP-624
Drug: Placebo
X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...
Invitation-only
Major Depressive Disorder
Drug: Azetukalner
Trial sponsors
X
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems